Skip to main content
Year archive

Torrent Pharmaceuticals Ltd. — 2022 filings

All 205 regulatory filings released by Torrent Pharmaceuticals Ltd. (TORNTPHARM) in 2022, sourced directly from the official regulator.

205 Filings
2022 Period
2022 filings (205)
Filing Released Lang
Trading Window
Regulatory Filings
2022-12-28 English
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading ....
Regulatory Filings
2022-12-28 English
Amalgamation/Merger
Regulatory Filings
2022-12-21 English
Intimation for approval of scheme of amalgamation of Curatio Health Care (I) Private Limited with Company
Regulatory Filings
2022-12-21 English
Intimation of the Closure of Trading Window as per Company''s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons
Regulatory Filings
2022-12-15 English
Closure of trading window
Regulatory Filings
2022-12-15 English
Redemption
Regulatory Filings
2022-12-14 English
Partial Redemption of Non-Convertible Debentures
Regulatory Filings
2022-12-14 English
Press Release
Regulatory Filings
2022-12-14 English
Torrent Pharmaceuticals Ltd enters into co-marketing partnership with Boehringer Ingelheim India Private Limited to co- market its anti-diabetic drug and its fixed dose combinations in India
Regulatory Filings
2022-12-14 English
Newspaper Advertisements
Regulatory Filings
2022-12-08 English
Newspaper advertisement in respect of the transfer of shares to IEPF
Regulatory Filings
2022-12-08 English
Intimation of Loss of Share Certificates
Regulatory Filings
2022-12-06 English
Loss of share certificate
Regulatory Filings
2022-12-06 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-11-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-11-14 English
Intimation regarding issue of Non-Convertible Debentures on Private Placement basis
Regulatory Filings
2022-11-09 English
Debentures
Regulatory Filings
2022-11-09 English
Credit Rating
Regulatory Filings
2022-11-04 English
Credit Rating
Regulatory Filings
2022-11-04 English
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, it is hereby informed that India Ratings and Research Private Limited has affirmed / ....
Regulatory Filings
2022-11-04 English
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2022
Regulatory Filings
2022-10-28 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-10-28 English
In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference ....
Regulatory Filings
2022-10-28 English
In continuation of our letter dated 14-Oct-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference ....
Regulatory Filings
2022-10-21 English
Compliance as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-10-21 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-10-21 English
Reply to Clarification Sought- Financial Results
Regulatory Filings
2022-10-21 English
Related Party Transaction
Regulatory Filings
2022-10-21 English
Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Regulatory Filings
2022-10-21 English
Investor Presentation
Regulatory Filings
2022-10-21 English
Presentation to analysts on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2022
Regulatory Filings
2022-10-21 English
Outcome of Board Meeting
Regulatory Filings
2022-10-21 English
Submission / Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Regulatory Filings
2022-10-21 English
Intimation of Loss of Share Certificates
Regulatory Filings
2022-10-20 English
Loss of share certificate
Regulatory Filings
2022-10-20 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 21st October, 2022 at 06:30 P.M. to discuss the financial performance of the Company for the ....
Regulatory Filings
2022-10-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-10-14 English
General updates
Regulatory Filings
2022-10-14 English
With reference to our earlier intimation dated 27-Sep-22 in relation to acquisition of 100% stake in Curatio Health Care (I) Private Limited, we hereby wish to inform that the transaction ....
Regulatory Filings
2022-10-14 English
In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for ....
Regulatory Filings
2022-10-04 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2022 ,inter alia, to consider and approve We would like to inform ....
Regulatory Filings
2022-10-04 English
Board Meeting — Financial results/Other business matters
Regulatory Filings
2022-10-04 English
General updates
Regulatory Filings
2022-09-28 English
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, this is to inform you that: The USFDA inspected our manufacturing facility at Indrad, ....
Regulatory Filings
2022-09-28 English
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading ....
Regulatory Filings
2022-09-28 English
Closure of trading window
Regulatory Filings
2022-09-28 English
Presentation to analysts on acquisition of Curatio Health Care (I) Private Limited
Regulatory Filings
2022-09-27 English
Investor Presentation
Regulatory Filings
2022-09-27 English
Conference call with investors / analyst
Regulatory Filings
2022-09-27 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-27 English
Torrent Pharma to acquire Curatio Healthcare
Regulatory Filings
2022-09-27 English
Press Release
Regulatory Filings
2022-09-27 English
Acquisition
Regulatory Filings
2022-09-27 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Regulatory Filings
2022-09-27 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-09-17 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-09-17 English
Postal Ballot
Regulatory Filings
2022-09-09 English
This refers to the Postal Ballot Notice dated 29th July, 2022 sent to the shareholders of the Company seeking their approval on the items as detailed in the Notice. The e-voting facility ....
Regulatory Filings
2022-09-09 English
Intimation of Loss of Share Certificates
Regulatory Filings
2022-09-06 English
Loss of share certificate
Regulatory Filings
2022-09-06 English
Business Responsibility and Sustainability Reporting (BRSR)
Regulatory Filings
2022-09-01 English
Redemption
Regulatory Filings
2022-08-30 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures ....
Regulatory Filings
2022-08-30 English
This is with reference to e-mail received from BSE on 25th August, 2022, referring to the news item appeared in https://economictimes.indiatimes.com captioned 'Torrent Pharma set to acquire ....
Regulatory Filings
2022-08-25 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that ICRA Limited has upgraded the long term credit rating of ....
Regulatory Filings
2022-08-25 English
Credit Rating
Regulatory Filings
2022-08-25 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-09 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-09 English
Newspaper Advertisements
Regulatory Filings
2022-08-09 English
Newspaper advertisement for completion of dispatch of Postal Ballot Notice
Regulatory Filings
2022-08-09 English
In furtherance of our intimation dated 29th July, 2022 and in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed ....
Regulatory Filings
2022-08-08 English
Postal Ballot
Regulatory Filings
2022-08-08 English
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter ended 30th June, 2022
Regulatory Filings
2022-08-05 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-05 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-01 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-08-01 English
Annual General Meeting
Regulatory Filings
2022-07-30 English
Declaration of Results of Voting
Regulatory Filings
2022-07-30 English
In continuation of our letter dated 21-Jul-22 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference ....
Regulatory Filings
2022-07-30 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-07-30 English
Proceedings of 49th Annual General Meeting of the Company held on 29th July, 2022
Regulatory Filings
2022-07-29 English
Annual General Meeting
Regulatory Filings
2022-07-29 English
Appointment of Company Secretary and Compliance Officer
Regulatory Filings
2022-07-29 English
Appointment
Regulatory Filings
2022-07-29 English
Presentation to analysts on unaudited Consolidated Financial Results for the quarter ended 30th June, 2022
Regulatory Filings
2022-07-29 English
Investor Presentation
Regulatory Filings
2022-07-29 English
Press Release
Regulatory Filings
2022-07-29 English
Appointment
Regulatory Filings
2022-07-29 English
Appointment of Manish Choksi as Independent Director of the Company
Regulatory Filings
2022-07-29 English
Submission/ Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Regulatory Filings
2022-07-29 English
Submission/ Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Regulatory Filings
2022-07-29 English
Outcome of Board Meeting
Regulatory Filings
2022-07-29 English
Appointment
Regulatory Filings
2022-07-29 English
Appointment of Aman Mehta as Whole-time Director of the Company
Regulatory Filings
2022-07-29 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-07-21 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 29th July, 2022 at 07:30 P.M. to discuss the financial performance of the Company for the quarter ....
Regulatory Filings
2022-07-21 English
This has reference to the article published in Business Standard on July 20, 2022 with title "Torrent Pharma expected to enter diagnostics space in next 2-3 months". We would like to ....
Regulatory Filings
2022-07-21 English
General updates
Regulatory Filings
2022-07-21 English
Bonus
Regulatory Filings
2022-07-13 English
In furtherance to our letter dated 25-May-22, we would like to inform that the Company has allotted 16,92,22,720 Bonus equity shares of Rs. 5/- each on Wednesday, 13-Jul-22. The shares ....
Regulatory Filings
2022-07-13 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2022 ,inter alia, to consider and approve We would like to inform ....
Regulatory Filings
2022-07-11 English
Board Meeting — Financial results/Other business matters
Regulatory Filings
2022-07-11 English
Please find enclosed herewith the copies of Newspaper cuttings published in Financial Express (English & Gujarati) on 5th July, 2022 in connection with the 49th Annual General Meeting and ....
Regulatory Filings
2022-07-05 English
Newspaper Advertisements
Regulatory Filings
2022-07-05 English
Business Responsibility & Sustainability Report (BRSR)
Regulatory Filings
2022-07-04 English
Please find attached herewith soft copy of the Integrated Annual Report 2021-22 (comprising of Notice calling 49th Annual General Meeting (AGM) along with Audited Financial Statements, ....
Regulatory Filings
2022-07-04 English
Postal Ballot
Regulatory Filings
2022-07-01 English
This refers to the Postal Ballot Notice dated 25th May, 2022 sent to the shareholders of the Company seeking their approval on the items as detailed in the Notice. The e-voting ....
Regulatory Filings
2022-07-01 English
Newspaper advertisement - Intimation of the 49th Annual General Meeting of the Company through Video-Conferencing / Other Audio Visual Means ('VC / OAVM') facility
Regulatory Filings
2022-07-01 English
Newspaper Advertisements
Regulatory Filings
2022-07-01 English
Loss of share certificate
Regulatory Filings
2022-06-29 English
Intimation of Issue of Duplicate Share Certificate
Regulatory Filings
2022-06-29 English
Record Date
Regulatory Filings
2022-06-29 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Monday, 11th July, 2022 as the Record Date for the purpose of determining the names of Members who shall be entitled ....
Regulatory Filings
2022-06-29 English
Closure of trading window
Regulatory Filings
2022-06-29 English
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading ....
Regulatory Filings
2022-06-29 English
Loss of share certificate
Regulatory Filings
2022-06-03 English
Intimation of Loss of Share Certificates
Regulatory Filings
2022-06-03 English
Newspaper Advertisements
Regulatory Filings
2022-05-31 English
Newspaper advertisement in respect of the transfer of shares to IEPF
Regulatory Filings
2022-05-31 English
Newspaper Advertisements
Regulatory Filings
2022-05-31 English
Newspaper advertisement for completion of dispatch of Postal Ballot Notice
Regulatory Filings
2022-05-31 English
Postal Ballot
Regulatory Filings
2022-05-30 English
In furtherance of our intimation dated 25th May, 2022 and in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed ....
Regulatory Filings
2022-05-30 English
Transcript of Conference call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2022
Regulatory Filings
2022-05-30 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-30 English
Loss of share certificate
Regulatory Filings
2022-05-27 English
Intimation of Loss of Share Certificates
Regulatory Filings
2022-05-27 English
Press Release
Regulatory Filings
2022-05-26 English
Torrent Pharma acquires 4 Brands from Dr. Reddy's laboratories
Regulatory Filings
2022-05-26 English
In continuation of our letter dated 20-May-22 and pm''suant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirem??nts) Regulations, 2015, the audio recording of ....
Regulatory Filings
2022-05-25 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-25 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-25 English
Bonus
Regulatory Filings
2022-05-25 English
Dividend
Regulatory Filings
2022-05-25 English
Dividend
Regulatory Filings
2022-05-25 English
Torrent Pharmaceuticals Ltd has informed BSE that the Board has at its meeting held on May 25, 2022, approved / recommended, inter alia, the following: - Issue of Bonus shares in ....
Regulatory Filings
2022-05-25 English
Pursuant to regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed the disclosure of Related Paity Transactions for the half ....
Regulatory Filings
2022-05-25 English
Board has recommended to the members Issue of Bonus shares in the ratio of 1: 1 i.e. one equity share for each fully paid up equity share held as on record date fixed for the purpose
Regulatory Filings
2022-05-25 English
Board has recommended to the members A final dividend of Rs. 23/- (460%) per equity share of Rs. 5/- each including the special dividend of Rs. 15/~ per equity share. The final dividend ....
Regulatory Filings
2022-05-25 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Monday, 6th June, 2022 as the Record Date for taking record of the Members of the Company entitled for the purpose ....
Regulatory Filings
2022-05-25 English
Recommended to the members to obtain enabling approval for issuance of Equity Shares including Convertible Bonds/ Debentures through Qualified Institutional Placement (QIP) and / or Depository ....
Regulatory Filings
2022-05-25 English
Board has recommended to the members A final dividend of Rs. 23/- (460%) per equity share of Rs. 5/- each including the special dividend of Rs. 15/~ per equity share.
Regulatory Filings
2022-05-25 English
Disclosure pursuant to Regulation 30 of (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")
Regulatory Filings
2022-05-25 English
Press Release
Regulatory Filings
2022-05-25 English
Presentation to analysts on Audited Financial Results for the quarter and year ended 31st March, 2022
Regulatory Filings
2022-05-25 English
Related Party Transaction
Regulatory Filings
2022-05-25 English
Record Date
Regulatory Filings
2022-05-25 English
Investor Presentation
Regulatory Filings
2022-05-25 English
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")
Regulatory Filings
2022-05-25 English
Disclosure pursuant to Regulation 30 read with Schedule III and Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015, ("Listing Regulations")
Regulatory Filings
2022-05-25 English
Dividend
Regulatory Filings
2022-05-25 English
Outcome of Board Meeting
Regulatory Filings
2022-05-25 English
Financial Result Updates
Regulatory Filings
2022-05-25 English
In furtherance to the earlier communication dated 6th May, 2022 with respect to intimation of the date of the Board meeting scheduled to be held on May 25, 2022, Torrent Pharmaceuticals ....
Regulatory Filings
2022-05-23 English
Board Meeting — Bonus
Regulatory Filings
2022-05-21 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve In furtherance to ....
Regulatory Filings
2022-05-21 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th May, 2022 at 07:00 P.M. to discuss the financial performance of the Company for the quarter ....
Regulatory Filings
2022-05-20 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-20 English
Loss of share certificate
Regulatory Filings
2022-05-16 English
Intimation of Issue of Duplicate Share Certificates
Regulatory Filings
2022-05-16 English
General updates
Regulatory Filings
2022-05-12 English
Appointment of Dr. Maurice Chagnaud as an Additional and Independent Director of the Company
Regulatory Filings
2022-05-11 English
Appointment
Regulatory Filings
2022-05-11 English
Appointment of Dr. Maurice Chagnaud as an Additional and Independent Director of the Company
Regulatory Filings
2022-05-11 English
Outcome of Board Meeting
Regulatory Filings
2022-05-11 English
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 08-Feb-19, kindly find enclosed ....
Regulatory Filings
2022-05-11 English
Torrent Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors will be held on May 25, 2022, inter alia, to consider and approve the Audited Financial Results of ....
Regulatory Filings
2022-05-06 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2022 ,inter alia, to consider and approve 1. A meeting of the ....
Regulatory Filings
2022-05-06 English
Board Meeting — Dividend/Financial results/Fund raising
Regulatory Filings
2022-05-06 English
Credit Rating
Regulatory Filings
2022-04-28 English
Intimation of Credit rating
Regulatory Filings
2022-04-28 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures ....
Regulatory Filings
2022-04-22 English
Redemption
Regulatory Filings
2022-04-22 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings
2022-04-16 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2022-04-16 English
In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for ....
Regulatory Filings
2022-04-12 English
With reference to the above, we send herewith a copy of the Compliance Certificate under Regulation 40(9) of the SEBI (LODR) Regulations, 2015 issued by RPAP & Co., Practicing Company Secretaries, ...
Regulatory Filings
2022-04-12 English
Disclosure under SEBI Takeover Regulations
Financial Supplement Data
2022-04-05 English
Closure of trading window
Regulatory Filings
2022-03-25 English
Pursuant to Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons of the Company (''Code'') and applicable SEBI Regulations, we would like to inform you that trading ....
Regulatory Filings
2022-03-25 English
Torrent Pharma enters into licensing agreement with Medicine Patent Pool to manufacture and commercialise generic version of Pfizer Oral COVID-19 Treatment
Regulatory Filings
2022-03-17 English
Press Release
Regulatory Filings
2022-03-17 English
General updates
Regulatory Filings
2022-03-16 English
The Company has been informed that the name of Registrar & Share Transfer Agent (RTA) has been changed from KFIN TECHNOLOGIES PRIVATE LIMITED to KFIN TECHNOLOGIES LIMITED pursuant to conversion ....
Regulatory Filings
2022-03-16 English
Loss of Share Certificates
Regulatory Filings
2022-01-28 English
Intimation of Issue of Duplicate Shares
Regulatory Filings
2022-01-28 English
Dividend Updates
Regulatory Filings
2022-01-25 English
Date of payment of dividend
Regulatory Filings
2022-01-25 English
We would like to inform that the Board has at its meeting held today approved an interim dividend of Rs. 25/- (500 %) per equity share of Rs. 5/- fully paid up. The dividend is expected ....
Regulatory Filings
2022-01-25 English
The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2021 to be made to analysts is enclosed for your records.
Regulatory Filings
2022-01-25 English
Dividend
Regulatory Filings
2022-01-25 English
Investor Presentation
Regulatory Filings
2022-01-25 English
We would like to inform that the Board has at its meeting held today approved, inter-alia, the following: 1) Audited Standalone Financial Results along with audit report thereon ....
Regulatory Filings
2022-01-25 English
Financial Result Updates
Regulatory Filings
2022-01-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-11 English
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 25th January, 2022 at 06:00 P.M. to discuss the financial performance of the Company for the ....
Regulatory Filings
2022-01-11 English
Torrent Pharmaceuticals Ltd has informed BSE that the Company has fixed February 03, 2022 as the Record Date for the purpose of payment of lnterim Dividend, if declared.
Regulatory Filings
2022-01-11 English
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Thursday, 3rd February, 2022 as the Record Date for taking record of the Members of the Company for the purpose of ....
Regulatory Filings
2022-01-10 English
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/01/2022 ,inter alia, to consider and approve We would like to inform ....
Regulatory Filings
2022-01-10 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2022-01-10 English
Intimation of Issue of Duplicate Share Certificate
Regulatory Filings
2022-01-07 English
Loss of Share Certificates
Regulatory Filings
2022-01-07 English
Loss of Share Certificates
Regulatory Filings
2022-01-07 English